Delivery Order SPE2DB22D2206-SPE2DB25FJV48
Award Date 9/9/25
Potential Completion Date 9/10/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Moxifloxacin 400 mg/250 mL bags. This competitively awarded, non-set-aside delivery order has a ceiling value of $1,495.80 with a firm fixed price and is scheduled for completion by July 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packs of 50, with a ceiling value of $1,188.33. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $1,364.93 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count packages). The contract utilizes a firm fixed-price delivery order structure with an ultimate completion date of September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating it was awarded through open competition....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,588.95 on August 4, 2025, for the supply of Moxifloxacin 400 mg/250 ml bags through the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of August 5, 2025. The place of performance is listed as the vendor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Moxifloxacin 400mg in 30-count units, with a ceiling value of $5,476.42 and a completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Moxifloxacin is a broad-spectrum...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50 units. This contract is valued at $2,070.00 with a firm fixed price structure and an ultimate completion date of August 20, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Moxifloxacin HCl 400 mg tablets (30-count packaging) with a ceiling value of $1,596.49. This firm fixed-price delivery order is set to be completed by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded without set-aside designation through competitive...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50s. This is a firm fixed price delivery order with a ceiling value of $1,852.51 and an ultimate completion date of August 18, 2025. The award was competitively awarded with no set-aside designation, and performance will be executed from the vendor's corporate office in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,380.00 for Moxifloxacin HCL 400 mg tablet unit dose packs of 50 units. This firm fixed price, competitively awarded contract was executed on August 20, 2025, with an ultimate completion date of August 21, 2025. The delivery order was fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This award carries no set-aside designation, reflecting...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for moxifloxacin hydrochloride 400 mg tablets in unit dose packaging of 50s, with a ceiling value of $2,070.00. Awarded on August 14, 2025, this firm fixed-price delivery order is due for completion by August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, consistent with...